Medco, Sanofi Partner on PGx, Comparative Effectiveness | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Medco Health Solutions announced on Wednesday that it, its wholly owned subsidiary United BioSource, and Sanofi have entered into a global, multi-year agreement to improve patient care in real-world settings.

The partnership will leverage several capabilities, including personalized medicine and pharmacogenomics, health economics, and safety research, as well as clinical/adherence support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.